Edge Rewrite
location Source code View original
// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a290a95c3f783488

Jump to content

AMNOG

From Wikipedia, the free encyclopedia

The Arzneimittelmarkt-Neuordnungsgesetz (AMNOG, English translation: "Pharmaceuticals Market Reorganisation Act") is a German law relating to the marketing of pharmaceutical products in Germany. It requires drug manufacturers to submit evidence to the Federal Joint Committee (Germany) that shows whether their new products have an added benefit compared to previous products.[1] It is credited with reducing the cost of healthcare in Germany.[2]

References

[edit]
  1. ↑ "AMNOG - evaluation of new pharmaceutical". GKV-Spitzenverband. 2014. Retrieved 27 May 2014.{{cite web}}: CS1 maint: deprecated archival service (link)
  2. ↑ Olga Khazan (22 May 2014). "Why Medicine Is Cheaper in Germany". The Atlantic.

See also

[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=AMNOG&oldid=1291553715"